Related Experiment Video
Updated: May 8, 2026
04:32
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
Thrombotic thrombocytopenic purpura
1Division of Hematology, Veterans Administration Medical Center, Miami, Florida.
Annual Review of Medicine
|January 1, 1988
Summary
A specific platelet agglutinating factor may trigger thrombotic thrombocytopenic purpura (TTP) in some patients. Identifying TTP subgroups and modifying factors can improve disease understanding and therapy.
Area of Science:
- Hematology
- Vascular Biology
- Immunology
Background:
- Platelet thrombus formation is crucial in small vessel function.
- Thrombus formation and dissolution are regulated by complex biological processes.
- Thrombotic thrombocytopenic purpura (TTP) involves intravascular platelet agglutination.
Purpose of the Study:
- To investigate the role of a specific platelet agglutinating factor in a subset of TTP patients.
- To identify and classify TTP patient subgroups based on triggering agents.
- To clarify the influence of modifying factors on TTP pathogenesis.
Main Methods:
- Review of recent evidence on TTP.
- Analysis of platelet agglutinating factors.
- Classification of TTP patient subgroups.
Main Results:
- Evidence suggests a specific platelet agglutinating factor triggers intravascular platelet agglutination in some TTP patients.
- Identification of distinct TTP subgroups may be possible.
- Modifying factors play a role in TTP.
Conclusions:
- Understanding TTP requires identifying specific triggering agents and patient subgroups.
- Further research into modifying factors is essential for improved TTP therapy.
- Subgroup classification can lead to more targeted and effective TTP treatments.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...